Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pilulka Lekarny AS's share price for the quarter that ended in Dec. 2025 was Kč170. Pilulka Lekarny AS's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 3 Mil. Therefore, Pilulka Lekarny AS's market cap for the quarter that ended in Dec. 2025 was Kč460 Mil.
Pilulka Lekarny AS's quarterly market cap
declined
from Jun. 2024 (Kč348 Mil) to Dec. 2024 (Kč291 Mil) but then
increased
from Dec. 2024 (Kč291 Mil) to Dec. 2025 (Kč460 Mil).
Pilulka Lekarny AS's annual market cap
declined
from Dec. 2023 (Kč666 Mil) to Dec. 2024 (Kč291 Mil) but then
increased
from Dec. 2024 (Kč291 Mil) to Dec. 2025 (Kč460 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pilulka Lekarny AS's Enterprise Value for Today is Kč347 Mil.
Pilulka Lekarny AS (XPRA:PINK) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Pilulka Lekarny AS Market Cap Related Terms
Pilulka Lekarny AS Market Cap Historical Data
* Premium members only.
The historical data trend for Pilulka Lekarny AS's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pilulka Lekarny AS Market Cap Competitor Comparison
For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pilulka Lekarny AS Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's Market Cap distribution charts can be found below:
* The bar in red indicates where Pilulka Lekarny AS's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Pilulka Lekarny AS's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pilulka Lekarny AS (XPRA:PINK) has a Market Cap of Kč311 Mil as of Jul. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pilulka Lekarny AS and its competitors. According to the industry distribution chart, Pilulka Lekarny AS ranks #542 out of 692 companies in the Healthcare Providers & Services industry, placing it in the top 78.3%.
Is Pilulka Lekarny AS's Market Cap too high?
Pilulka Lekarny AS's current Market Cap is Kč311 Mil. Based on the distribution chart, Pilulka Lekarny AS ranks #542 out of 692 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pilulka Lekarny AS has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's Market Cap compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Pilulka Lekarny AS ranks #542 out of 692 companies for Market Cap. This places Pilulka Lekarny AS in the lower half of its industry. The industry median Market Cap is 98.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 98.60, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pilulka Lekarny AS and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 98.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pilulka Lekarny AS's current Market Cap is Kč311 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Fairly Valued. The stock's GF Value™ is Kč113.93, compared to a current price of Kč115.00 — trading 0.9% above its estimated fair value. The current Market Cap is Kč311 Mil. Pilulka Lekarny AS's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current Market Cap is Kč311 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?
Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be overvalued.
The current stock price of Kč115.00 is trading 0.9% above its estimated GF Value™ of Kč113.93.
GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.
Key valuation signals for XPRA:PINK:
Market Cap: Kč311 Mil
GF Value™: Kč113.93 vs. price of Kč115.00 (0.9% above fair value)
No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
49GF Score
Get the complete analysis for XPRA:PINK
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPRA:PINK has been successfully added to your 